FDA Grants Full Approval To Gilead’s Remdesivir For Treatment Of COVID-19 In Children Aged 28 Days And Older

Reuters (4/25, Mishra) reports that on Monday, the Food and Drug Administration “granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc’s drug remdesivir [Veklury].” This “comes months after the age...